To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
A better way to copy DNA
15-07-2004: Scientists have developed a new method for DNA amplification that could replace the polymerase chain reaction (PCR). In the August issue of EMBO reports, Huimin Kong and colleagues at New England Biolabs (Beverly, MA, USA) describe a way to copy mass amounts of DNA that has significant advantages over PCR. The new technique is called HDA (helicase-dependent amplification). The new technique is called HDA (helicase-dependent amplification). HDA is as simple as PCR, but has significant advantages. PCR requires thermocycling to heat and cool a sample of DNA, to allow denaturation (separating DNA into single strands) and synthesis (copying single strands to create new double-stranded DNA).
HDA instead mimics nature's method of replicating DNA by using a helicase enzyme to denature the DNA. As a result, the entire HDA reaction can be performed at one temperature that is optimized for synthesis, eliminating the need for an expensive and power-hungry thermocycler. HDA could expand the application of DNA amplification to situations in which the requirements for PCR have made it prohibitive. The costs are likely to be more modest and, most importantly, the simplicity of HDA makes it suitable for the development of hand-held DNA diagnostic devices that could be used to detect pathogens at the point-of-care or in the field.
Watchlist
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Vivacta Initiates Development of Point of Care Test for Vitamin D
- 4Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 5A light switch inside the brain
- 6Researchers divide enzyme to conquer genetic puzzle
- 7New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 8Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 9Merck & Co., Inc. Opens Asia Pacific Regional Headquarters in Singapore
- 10Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
